Concepedia

Kras Mutation Testing

KRAS Mutation Testing is a molecular diagnostic assay that identifies somatic mutations in the KRAS gene, particularly within codons 12, 13, and 61, to determine the mutational status of tumors for prognostic, predictive, or therapeutic decision-making in cytopathology and oncology.

1.1K

Publications

80.3K

Citations

8.8K

Authors

2K

Institutions

Publications per year

2017–2026

362

Parents

Publications

1.1K

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine · 2009 · 3.9K citations · Full text

, , +17

Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer

Jean‐Yves Douillard, Kelly S. Oliner, Salvatore Siena et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

, , +15

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Sandra Misale, Rona Yaeger, Sebastijan Hobor et al. · Nature · 2012 · 1.9K citations · Full text

, , +16

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

Thomas F. Imperiale, David F. Ransohoff, Steven H. Itzkowitz et al. · New England Journal of Medicine · 2014 · 1.9K citations

, , +17

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor <i>KRAS</i> and <i>BRAF</i> Mutation Status

Eric Van Cutsem, Claus-Henning Köhne, István Láng et al. · Journal of Clinical Oncology · 2011 · 1.9K citations · Full text

, , +17

1–5 of 1.1K

Authors

8.8K

  1. MG
    Mark G. Kris

    Memorial Sloan Kettering Cancer Center, United States

    17 publications · 3.8K citations

    16

    h-index

  2. EV
    Eric Van Cutsem

    KU Leuven, Belgium

    16 publications · 8.3K citations

    16

    h-index

  3. PA
    Pasi A. Jänne

    Dana-Farber Cancer Institute, United States

    14 publications · 1.9K citations

    14

    h-index

  4. ML
    Marc Ladanyi

    Memorial Sloan Kettering Cancer Center, United States

    13 publications · 3.7K citations

    13

    h-index

  5. GJ
    Gregory J. Riely

    Memorial Sloan Kettering Cancer Center, United States

    12 publications · 3.8K citations

    12

    h-index

1–5 of 8.8K

Institutions

2K

  1. Memorial Sloan Kettering Cancer Center

    New York, United States

    33 h-index

    281 publications

    66.3K citations

  2. Inserm

    Paris, France

    31 h-index

    158 publications

    27.6K citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    25 h-index

    129 publications

    15.3K citations

  4. Dana-Farber Cancer Institute

    Boston, United States

    22 h-index

    125 publications

    23.1K citations

  5. Harvard University

    Cambridge, United States

    21 h-index

    128 publications

    16.5K citations

  6. Johns Hopkins University

    Baltimore, United States

    21 h-index

    148 publications

    12.4K citations

  7. KU Leuven

    Leuven, Belgium

    17 h-index

    46 publications

    11.9K citations

  8. National Cancer Center Hospital East

    Kashiwa, Japan

    17 h-index

    111 publications

    3.7K citations

1–8 of 2K

Venues

  1. British Journal of Cancer

    BJC · 30 publications · 3.5K citations

    28

    h-index

  2. PLoS ONE

    45 publications · 2.3K citations

    28

    h-index

  3. Journal of Thoracic Oncology

    29 publications · 2.9K citations

    27

    h-index

  4. Journal of Clinical Oncology

    56 publications · 11.7K citations

    26

    h-index

  5. Journal of Molecular Diagnostics

    JMD · 24 publications · 2.6K citations

    22

    h-index

1–5